NCT02551094View on ClinicalTrials.gov

Colchicine Cardiovascular Outcomes Trial (COLCOT)

PHASE3CompletedINTERVENTIONAL
Enrollment

4,745

Participants

Timeline

Start Date

December 4, 2015

Primary Completion Date

July 17, 2019

Study Completion Date

July 17, 2019

Conditions
Coronary Artery DiseaseMyocardial Infarction
Interventions
DRUG

colchicine

0.5 mg tablet taken once a day

DRUG

colchicine placebo

sugar pill manufactured to mimic colchicine 0.5 mg tablet

Trial Locations (1)

H1T1C8

Montreal Heart Institute, Montreal

All Listed Sponsors
lead

Montreal Heart Institute

OTHER

NCT02551094 - Colchicine Cardiovascular Outcomes Trial (COLCOT) | Biotech Hunter | Biotech Hunter